Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > ANDA - 505(b)(2)

<< Previous

Bullboard Posts

Next >>

Comment by alleyesonmeon Sep 02, 2024 1:05pm

103 Views

Post# 36205253

RE:ANDA - 505(b)(2)

Keith said on the q1 cc that their busy preparing for the epidiolex launch in the U.S"...fingers crossed we have news of a release date before Y/E...should move the needle...lots of opportunity with dronabinol in the E.U and I'm surprised no DMF for THC which would allow entry into the U.S where a shortage exists.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide